Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in
Status
ACTIVE
Global HQ
Pennsylvania, United States
Countries of investment
  • USA
Investment stages
  • Seed
  • Series A
  • Series B
  • Series C
Industries
  • Manufacturing
  • Pharma
  • Diagnostics
  • Biotechnology
  • Health Tech
  • Medical Devices
  • Digital Health
About
BioVentures MedTech Funds invests in cutting-edge medical technology companies to improve global healthcare outcomes.
Min check size
$100K
Max check size
$38.9M
Fund size
NPS

Investment Thesis

BioVentures Investors focuses on medtech and healthcare innovations, leveraging deep industry expertise to support transformative companies. They prioritize investments that can significantly impact patient care and generate substantial returns.
Lead investor
Co Invest
Number of exits
Preferred contact method

Manager's Experience

Backed by a robust foundation in venture capital, the fund manager has executed over 40 investments across diverse sectors, focusing primarily on technology and consumer-driven startups. With experience in both early-stage and growth-stage investments, a strategic emphasis on India and Southeast Asia has yielded multiple successful exits. Built a track record of identifying high-potential ventures, the manager leverages deep market insights to drive value creation. Has led a dynamic portfolio that showcases adaptability and foresight in a rapidly evolving investment landscape.

BioVentures Investors Contacts Information

Primary contact

Secondary contact

Team

Tony Lyons

Peter Feinstein

Marc Goldberg

Marc Goldberg

Jeffrey Barnes

Wayne Johnson

Halina Niedzwiecki

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp